Published in Am J Pathol on April 01, 1989
Virulence of enterococci. Clin Microbiol Rev (1994) 4.32
Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl Environ Microbiol (2001) 3.19
Pheromone-inducible conjugation in Enterococcus faecalis: interbacterial and host-parasite chemical communication. J Bacteriol (1995) 2.03
Roles of antibodies and complement in phagocytic killing of enterococci. Infect Immun (1994) 1.46
Characterization of a class of nonformylated Enterococcus faecalis-derived neutrophil chemotactic peptides: the sex pheromones. Proc Natl Acad Sci U S A (1990) 1.22
Identification of the cAD1 sex pheromone precursor in Enterococcus faecalis. J Bacteriol (2002) 1.22
Evidence of the proinflammatory role of Enterococcus faecalis in polymicrobial peritonitis in rats. Infect Immun (1997) 0.97
Tales of conjugation and sex pheromones: A plasmid and enterococcal odyssey. Mob Genet Elements (2011) 0.88
A genetic determinant in Streptococcus gordonii Challis encodes a peptide with activity similar to that of enterococcal sex pheromone cAM373, which facilitates intergeneric DNA transfer. J Bacteriol (2010) 0.87
Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor. Protein Sci (1993) 0.84
Enterococcus faecium stimulates human neutrophils via the formyl-peptide receptor 2. PLoS One (2012) 0.78
N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci U S A (1975) 9.24
Plasmids, drug resistance, and gene transfer in the genus Streptococcus. Microbiol Rev (1981) 7.86
The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils. J Exp Med (1976) 7.57
Plasmid transfer in Streptococcus faecalis: production of multiple sex pheromones by recipients. Plasmid (1979) 7.20
Bacterial factors chemotactic for polymorphonuclear leukocytes. Am J Pathol (1968) 5.77
The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase. J Exp Med (1968) 4.79
Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods (1981) 4.41
Streptococcus faecalis sex pheromone (cAM373) also produced by Staphylococcus aureus and identification of a conjugative transposon (Tn918). J Bacteriol (1985) 3.84
The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J Immunol (1975) 3.50
Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J Biol Chem (1984) 3.32
Modulating influence of chemotactic factor-induced cell adhesiveness on granulocyte function. J Clin Invest (1979) 2.30
Granulocyte activation by endotoxin. I. Correlation between adherence and other granulocyte functions, and role of endotoxin structure on biologic activity. J Immunol (1983) 2.06
Isolation and structure of bacterial sex pheromone, cPD1. Science (1984) 1.92
Some interrelations of neutrophil chemotaxis, lysosomal enzyme secretion, and phagocytosis as revealed by synthetic peptides. Am J Pathol (1976) 1.86
Isolation and structure of the bacterial sex pheromone, cAD1, that induces plasmid transfer in Streptococcus faecalis. FEBS Lett (1984) 1.73
Superoxide production induced in rabbit polymorphonuclear leukocytes by synthetic chemotactic peptides and A23187. Am J Pathol (1979) 1.51
Further studies on the structural requirements for synthetic peptide chemoattractants. Biochemistry (1980) 1.40
Neutrophil leucocyte chemotaxis: a simplified assay for measuring polarizing responses to chemotactic factors. J Immunol Methods (1985) 1.35
Formyl peptide chemoattractants: a model of the receptor on rabbit neutrophils. Biochemistry (1982) 1.17
Purification and characterization of neutrophil chemotactic factors of Streptococcus sanguis. Biochim Biophys Acta (1983) 1.16
Cytotaxin receptors of neutrophils: evidence that F-methionyl peptides and pepstatin share a common receptor. Infect Immun (1979) 1.02
Pepstatin A--a human leukocyte chemoattractant. Clin Immunol Immunopathol (1979) 0.93
Structural requirements for formyl homooligopeptide chemoattractants. Biochemistry (1984) 0.90
Antibiotics and peptides with agonist and antagonist chemotactic activity. Biochem Biophys Res Commun (1978) 0.90
Assays of leukocyte chemotaxis. Annu Rev Med (1986) 0.90
Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J Immunol (1978) 6.04
Anaphylatoxins: C3a and C5a. Adv Immunol (1978) 3.44
Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1978) 3.08
Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a. J Immunol (1976) 2.90
Determination of the tryptophan content of proteins by ion exchange chromatography of alkaline hydrolysates. J Biol Chem (1972) 2.72
Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med (1981) 2.63
Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology (1975) 2.62
The alternative pathway C3/C5 convertase: chemical basis of factor B activation. J Immunol (1979) 2.58
Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a. J Biol Chem (1978) 2.32
Human anaphylatoxin (C3a) from the third component of complement. Primary structure. J Biol Chem (1975) 2.08
Structure and function of the anaphylatoxins. Springer Semin Immunopathol (1984) 2.07
Nucleotide sequence of cDNA and derived amino acid sequence of human complement component C9. Proc Natl Acad Sci U S A (1984) 2.01
Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J Biol Chem (1992) 1.96
Purification and partial characterization of human and porcine C3a anaphylatoxin. J Biol Chem (1975) 1.82
Requirement and role of C5a in acute lung inflammatory injury in rats. J Clin Invest (1996) 1.77
Isolation of three separate anaphylatoxins from complement-activated human serum. Mol Cell Biochem (1981) 1.70
Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J Immunol (2000) 1.57
A modified method for chemotaxis under agarose. J Immunol Methods (1979) 1.55
Heat-induced fragmentation of human alpha 2-macroglobulin. J Biol Chem (1979) 1.53
The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a. Crit Rev Immunol (1981) 1.51
Role of cell surface contact in the kinetics of superoxide production by granulocytes. J Clin Invest (1983) 1.48
Pulmonary injury induced by C3a and C5a anaphylatoxins. Am J Pathol (1980) 1.48
Endotoxin-induced shock in the rat. A role for C5a. Am J Pathol (1989) 1.44
Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J Immunol (1983) 1.44
Human C5a and C5a analogs as probes of the neutrophil C5a receptor. Mol Immunol (1980) 1.41
Regulation of immune response by components of the complement cascade and their activated fragments. Springer Semin Immunopathol (1983) 1.41
Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation. Proc Natl Acad Sci U S A (1983) 1.37
C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med (1995) 1.36
Neutrophil chemotactic factors promote leukocytosis. A common mechanism for cellular recruitment from bone marrow. J Immunol (1992) 1.36
C4a: the third anaphylatoxin of the human complement system. Proc Natl Acad Sci U S A (1979) 1.34
Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am J Pathol (1994) 1.28
Limited degradation of the third component (C3) of human complement by human leukocyte elastase (HLE): partial characterization of C3 fragments. Biochemistry (1977) 1.26
Structural changes accompanying enzymatic activation of human Hageman factor. J Clin Invest (1974) 1.25
Biochemistry and biology of anaphylatoxins. Complement (1986) 1.25
Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN). J Immunol (1985) 1.23
Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a. Proc Natl Acad Sci U S A (1981) 1.23
Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b. J Immunol (1983) 1.22
Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids. Anal Biochem (1984) 1.21
Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor. J Immunol (1993) 1.21
Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release. J Clin Invest (1979) 1.20
C5a-induced hemodynamic and hematologic changes in the rabbit. Role of cyclooxygenase products and polymorphonuclear leukocytes. Am J Pathol (1987) 1.18
Anaphylatoxin from the fifth component of porcine complement. Purification and partial chemical characterization. J Biol Chem (1979) 1.17
C5a-mediated release of interleukin 6 by human monocytes. Clin Immunol Immunopathol (1990) 1.16
Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin. Proc Natl Acad Sci U S A (1977) 1.16
C5a-dependent up-regulation in vivo of lung vascular P-selectin. J Immunol (1997) 1.15
Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis. Infect Immun (1996) 1.15
Circular dichroism of C3a anaphylatoxin. Effects of pH, heat, guanidinium chloride, and mercaptoethanol on conformation and function. J Biol Chem (1975) 1.14
Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit Care Med (1994) 1.14
Microvascular effects of anaphylatoxins C3a and C5a. J Immunol (1985) 1.13
Anaphylactic actions of platelet-activating factor. Am J Pathol (1981) 1.12
Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin. J Immunol (1982) 1.10
Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue. Am J Pathol (1983) 1.10
Response of human neutrophils to C5a: a role for the oligosaccharide moiety of human C5ades Arg-74 but not of C5a in biologic activity. J Immunol (1981) 1.10
Quantitative comparisons of neutrophil chemotaxis in four animal species. Clin Immunol Immunopathol (1980) 1.09
Leukotriene C4 production by murine mast cells: evidence of a role for extracellular leukotriene A4. Proc Natl Acad Sci U S A (1985) 1.08
Peptidergic pathway in human skin and rat peritoneal mast cell activation. Immunopharmacology (1994) 1.08
The extraction of leukotrienes (LTC4, LTD4, and LTE4) from tissue fluids: the metabolism of these mediators during IgE-dependent hypersensitivity reactions in lung. Anal Biochem (1983) 1.08
The active site of C3a anaphylatoxin. J Biol Chem (1980) 1.07
Inability of the C3a anaphylatoxin to promote cellular lysis. Nature (1980) 1.07
Biologic activity of synthetic analogues of C5a anaphylatoxin. J Immunol (1992) 1.07
Elucidation of a protease-sensitive site involved in the binding of calcium to C-reactive protein. Biochemistry (1989) 1.07
Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol (1999) 1.06
The pancreas as a source of cardiovascular cell activating factors. Microcirculation (2000) 1.06
Conformational analysis of COOH-terminal segments of human C3a. Evidence of ordered conformation in an active 21-residue peptide. J Biol Chem (1984) 1.05
A mechanism of action for anaphylatoxin C3a stimulation of mast cells. J Immunol (1992) 1.04
Regulation of IL-6 synthesis in human peripheral blood mononuclear cells by C3a and C3a(desArg). J Immunol (1999) 1.03
C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion. Immunopharmacology (2000) 1.03
Anaphylatoxin-mediated regulation of the immune response. II. C5a-mediated enhancement of human humoral and T cell-mediated immune responses. J Immunol (1983) 1.02
The primary structure of porcine C3a anaphylatoxin. J Immunol (1976) 1.01
Complete primary structure of human C4a anaphylatoxin. J Biol Chem (1981) 1.01
Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis. J Immunol (1992) 1.01
Regulation of B cell functions by C3a and C3a(desArg): suppression of TNF-alpha, IL-6, and the polyclonal immune response. J Immunol (1997) 1.00
The molecular architecture of human complement component C6. J Biol Chem (1989) 1.00
Complement factors and their receptors. Immunopharmacology (1997) 1.00
Anaphylatoxin-mediated regulation of human and murine immune responses. Fed Proc (1984) 1.00
The activation of human complement component C5 by a fluid phase C5 convertase. J Biol Chem (1983) 1.00
Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels. J Pharmacol Exp Ther (1984) 1.00
Psychopharmacological activity of anaphylatoxin C3a in rat hypothalamus. J Neuroimmunol (1983) 0.99
The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a. J Immunol (1995) 0.99
Anaphylatoxin generation in multisystem organ failure. J Trauma (1984) 0.98
Designing synthetic superagonists of C3a anaphylatoxin. Biochemistry (1991) 0.98
Multiple epithelial cell-derived factors enhance neutrophil survival. Regulation by glucocorticoids and tumor necrosis factor-alpha. Am J Respir Cell Mol Biol (1999) 0.97
C3d-K, a kallikrein cleavage fragment of iC3b is a potent inhibitor of cellular proliferation. J Immunol (1984) 0.97
Amino acid sequence of the anaphylatoxin from the fifth component of porcine complement. J Biol Chem (1980) 0.97
An amphiphilic structure of the ninth component of human complement. Evidence from analysis of fragments produced by alpha-thrombin. J Biol Chem (1982) 0.97
Oxidation of leukotrienes at the omega end: demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors. Proc Natl Acad Sci U S A (1984) 0.96
Plasma activation during splanchnic arterial occlusion shock. Shock (2000) 0.95
Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control. J Immunol (1990) 0.95
Effects of cardiopulmonary bypass on pulmonary leukostasis and complement activation. Arch Surg (1988) 0.95
Familial carboxypeptidase N deficiency. Ann Intern Med (1980) 0.93
Isolation and characterization of insoluble proteins of the synaptic plasma membrane. Arch Biochem Biophys (1968) 0.93
Demonstration of a specific C3a receptor on guinea pig platelets. J Immunol (1988) 0.93
Cleavage of human complement component C5 by cysteine proteinases from Porphyromonas (Bacteroides) gingivalis. Prior oxidation of C5 augments proteinase digestion of C5. Immunology (1996) 0.92
Circular dichroism studies of human factor H. A regulatory component of the complement system. Biochim Biophys Acta (1982) 0.92
Possible mechanism for in vitro complement activation in blood and plasma samples: futhan/EDTA controls in vitro complement activation. Clin Chem (1999) 0.92
Anaphylatoxin C5a modulation of an alpha-adrenergic receptor system in the rat hypothalamus. J Neuroimmunol (1985) 0.92
The preparation and characterization of an active derivative of bovine pancreatic deoxyribonuclease A formed by selective cleavage with alpha-chymotrypsin. J Biol Chem (1973) 0.92
Evidence for a role of the amino-terminal region in the biological activity of the classical anaphylatoxin, porcine C5a des-Arg-74. J Biol Chem (1985) 0.91